[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” next_background_color=”#ffffff” admin_label=”Hero” _builder_version=”4.24.3″ use_background_color_gradient=”on” background_color_gradient_type=”circular” background_color_gradient_direction_radial=”top right” background_color_gradient_stops=”rgba(255,255,255,0) 20%|rgba(1,77,183,0.9) 100%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”rgba(255,255,255,0)” background_color_gradient_start_position=”20%” background_color_gradient_end=”rgba(1,77,183,0.9)” background_image=”https:\/\/campbellneurosciences.com\/wp-content\/uploads\/2024\/06\/shutterstock_1028494843-scaled.jpg” custom_padding=”110px|0px|49px|0px|false|false” custom_padding_tablet=”50px||50px||true” custom_padding_phone=”|||” bottom_divider_style=”asymmetric” bottom_divider_height=”50px” bottom_divider_flip=”horizontal” bottom_divider_height_tablet=”90px” bottom_divider_height_phone=”80px” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ custom_width_px=”1280px” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”2_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.24.3″ text_font=”Montserrat||||||||” text_text_color=”rgba(255,255,255,0.7)” text_font_size=”20px” text_line_height=”1.8em” header_font=”Montserrat|700|||||||” header_font_size=”44px” header_line_height=”1.4em” header_6_font=”Montserrat|600||on|||||” header_6_text_color=”rgba(255,255,255,0.7)” header_6_font_size=”16px” header_6_letter_spacing=”2px” header_6_line_height=”1.5em” background_layout=”dark” max_width=”780px” custom_margin=”-65px|||||” text_font_size_tablet=”” text_font_size_phone=”15px” text_font_size_last_edited=”on|phone” header_font_size_tablet=”” header_font_size_phone=”28px” header_font_size_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”]<\/p>\n
Committed to establishing a biological basis for diagnosis and treatment of suicide and its causes, including Schizophrenia and other mental health disorders, thereby eliminating the stigma of the disease.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||” theme_builder_area=”post_content”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”-31px|auto||auto||” custom_padding=”0px|||||” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]<\/p>\n Thomas E. Ichim, Ph.D. \u2013 Chief Executive Officer and Director<\/strong><\/p>\n Dr. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. He has founded\/co-founded several companies including Batu Biologics, Inc., Medvax Pharma Corp, ToleroTech Inc, bioRASI, and OncoMune LLC. To date, he has published 121 peer-reviewed articles and is co-editor of the textbooks \u201cRNA Interference: From Bench to Clinical Translation\u201d and \u201cImmuno-Oncology Text Book.\u201d<\/p>\n Dr. Ichim is an ad-hoc editor and sits on several editorial boards. Dr. Ichim is an inventor on 135 patents and patent applications. Dr. Ichim has extensive experience with stem cell therapy and cellular product development through FDA regulatory pathways. Dr. Ichim spent over 7 years as the President and Chief Scientific Officer of Medistem, developing and commercializing a novel stem cell, the Endometrial Regenerative Cell, through drug discovery, optimization, preclinical testing, IND filing, and up through Phase II clinical trials with the FDA. Dr. Ichim has extensive experience in product development, regulatory filings, and business development.<\/p>\n Dr. Ichim has a BSc in Biology from the University of Waterloo, Waterloo, Ontario, Canada, an MSc in Microbiology and Immunology a University of Western Ontario, London, Ontario, Canada and a Ph.D. in Immunology from the University of Sciences Arts and Technology, Olveston Monserrat.<\/p>\n Jona Barnes,\u00a0Chief Financial Officer<\/strong><\/p>\n Jona Barnes is an accomplished financial executive with over 33 years of experience in private and public companies with exceptionally strong analytical skills.\u00a0\u00a0\u00a0<\/span>She is a result driven business partner able to establish vision and drive strategies to strengthen top and bottom-line performance through \u201croll up the sleeves\u201d hard work.<\/p>\n Jona holds a bachelor\u2019s degree in Accounting from San Diego State University.\u00a0\u00a0<\/span>She has worked for several public accounting firms. She is a partner for 25 years at Mallett & Barnes Tax Services representing corporate and individual clients with financial management, tax and complex audit issues.<\/p>\n Raymond Oliver \u2013 Chairman<\/strong><\/p>\n Raymond Oliver is CEO of Bear Creek Capital, Investor and entrepreneur. Mr. Oliver has assisted companies to get in position for financing and acceleration. Mr. Oliver been instrumental in sourcing capital for both private and public companies. Mr. Oliver have spent 35 years in the financial markets and has been on many sides. Mr. Oliver spent his first 10 years as a Series 7 and 63 licensed retail stockbroker managing all levels of equities markets. Mr. Oliver has spent many years working internally as an executive of multiple public companies. Mr. Oliver\u2019s Introductions resulted in millions of dollars in equity financing in both public and private <\/strong><\/p>\n James Veltmeyer, MD \u2013 Chief Medical Officer<\/strong><\/p>\n Dr. Veltmeyer is a board-certified family physician in La Mesa, California. A graduate of UC San Diego and the Ross University School of Medicine, he completed his residency through the UC San Francisco system where he became Chief of Family Medicine Residency, overseeing 36 doctors.<\/p>\n Dr. Veltmeyer, a member of the San Diego Critical Care Medical Group, has been elected for four years (2012, 2014, 2016, and 2017) by his colleagues in the San Diego County Medical Society as a \u201cPhysician of Exceptional Excellence,\u201d the most prestigious honor awarded to a \u201cTop Doctor\u201d in San Diego County. He is among a select group of San Diego physicians who was chosen four of the last fifteen years and he consistently ranks in the top 1% to 2% for patient satisfaction. He is currently the Chief of the Department of Family Medicine at Sharp Grossmont Hospital where he provides senior leadership to over 200 doctors.<\/p>\n Ms. Kalina O\u2019Connor \u2013 Founder and Chief Visionary Officer<\/strong><\/p>\n Kalina O\u2019Connor is the daughter of Kathleen Campbell, a victim of suicide who the Division Campbell Neurosciences is named after.\u00a0 Kalina is a serial entrepreneur having experience in the area of counselling and biotechnology business development.\u00a0 Kalina worked in various high-end suicide prevention\/rehabilitation organizations for a decade, which provided her an intimate understanding of the shortcomings that exist in current approach to brain understanding and reprogramming.\u00a0 Subsequently, Kalina was engaged with biotechnology organizations such as Therapsol and Bioscientific Holdings, providing introductions to licensing opportunities from academia.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Campbell Neurosciences, inc. Committed to establishing a biological basis for diagnosis and treatment of suicide and its causes, including Schizophrenia and other mental health disorders, thereby eliminating the stigma of the disease.Thomas E. Ichim, Ph.D. \u2013 Chief Executive Officer and Director Dr. Ichim is a seasoned biotechnology entrepreneur with a track record of scientific excellence. […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-140","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/comments?post=140"}],"version-history":[{"count":2,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/140\/revisions"}],"predecessor-version":[{"id":142,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/140\/revisions\/142"}],"wp:attachment":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/media?parent=140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
companies. Capital market specialties include introductions to retail brokers, institutions, money managers, small cap funds, analyst and others. Many have been in his network for over 30 years. Mr. Oliver\u2019s experience includes roles within several public and private companies whereas a value add he invested his own capital, secured top management and raised several millions of investment capital from the street. Mr. Oliver enjoys working with profitable companies that have strong management and are executing on their plan. Mr Oliver resides in Orlando with his wife and children for the past 30 years\u00a0<\/span><\/p>\n